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Abstract Previous research has indicated that children
with autism exhibit accelerated head growth (HG) in
infancy, although the timing of acceleration varies
between studies. We examined infant HG trajectory as
a candidate autism endophenotype by studying sibling
pairs. We retrospectively obtained serial head orbito-
frontal circumference measurements of: a) 48 sibling
pairs in which one (n=28) or both (n=20) sibs were
affected by an autism spectrum disorder (ASD); and b) 85
control male sibling pairs. Rate of HG of ASD subjects
was slightly accelerated compared to controls, but the
magnitude of difference was below the limit of reliability
of standard measurement methods. Sibling intra class
correlation for rate of HG was highly statistically
significant; the magnitude was significantly stronger
among autism-affected families (ICC=.63) than among
controls (ICC=.26), p<.01. Infant HG trajectory appears
familial—possibly endophenotypic—but was not a reli-
able marker of autism risk among siblings of ASD
probands in this sample.
Keywords Infancy.Headcircumference.Braingrowth.
Autism.Endophenotype.Pervasivedevelopmentaldisorder
Introduction
Although the specific neural mechanisms that underlie
autism spectrum disorders (ASD) are not yet known, it is
likely that subtle neuroanatomical abnormalities precede
the development of observable behavioral symptoms in
infants with ASD, and a suggested candidate marker for
those abnormalities is the trajectory of brain growth
during the first 2 years of life. A number of published
studies have provided evidence for time-limited acceler-
ation in early head growth, but the studies have varied in
methodology, sample size, and in the results, especially
with respect to the precise timing of that acceleration.
Given current evidence that there are disparate genetic
pathways to the development of ASD (Geschwind 2008),
and that our ability to control for these differences in
research studies is severely limited, it is possible that
sample heterogeneity has contributed to some of the
inconsistency in the findings to date.
In this report, we briefly review what is known about
early brain growth in ASD-affected infants, and present
findings from a study exclusively involving sibling pairs:
those concordantly affected by ASD, those discordant for
ASD, and those concordantly unaffected by ASD. ASDs
o c c u rf o u rt i m e sm o r ec o m m o n l yi nb o y st h a ni ng i r l sa n d
are heavily influenced by genetic factors: to our knowl-
edge, only one prior study of infant head growth trajectory
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study, Elder et al. (2008) investigated whether infant
siblings (n= 7 7 )o fc h i l d r e nw i t hA S Dw h oe x h i b i t e da n
atypical trajectory of head circumference (HC) growth
were more likely than those without an atypical HC
trajectory to develop autistic symptoms. Results showed
that infants who had larger HC at 12 months, and whose
HC growth rate decelerated more rapidly between
12 months and 24 months were more likely to exhibit
autism symptoms than infants with more typical HC
trajectories.
The results of prior research studies examining HC
trajectory in children are summarized in Table 1,w h i c h
also includes summary information for this study for
comparison. Following a report by Lainhart et al. (1997),
in which it was reported that among children with autism
and macrocephaly, 80% had shown no sign of macro-
cephaly at birth, Courchesne et al. (2003) reported that
HCs in 48 autistic subjects increased (on average) from
the 25th percentile at birth to the 84th percentile (in
reference to the FELS longitudinal study sample (Guo et
al. 1988)) during the interval from birth to 14 months of
age. Redcay and Courchesne (2005) performed a meta-
analysis of 15 studies of head circumference/brain volume
in autism that had been conducted prior to 2005 and
concluded that there was evidence for both pathological
brain growth and arrest of growth during the first years of
life. Fukumoto et al. (2008) subsequently observed that
abnormalities in HC trajectory in autism began as early as
the first month of life.
H a z l e t te ta l .( 2005) conducted one of the largest
studies to date, and one that employed both head measure-
ments and structural brain MRI. Their study suggested that
head growth acceleration in autism might begin somewhat
later. They compared 18–35 month old children diagnosed
with autism (n=113) to a normal control group using
measurements of a) brain volume (structural MRI), b)
retrospectively-obtained head circumference measure-
ments from the time of birth, or c) both. The analyses
from both measurement methods supported an increase in
t h er a t eo fh e a dg r o w t hi nc h i l d r e nw i t ha u t i s mb e g i n n i n g
at around 12 months of age and persisting through the
second year of life. Of note is that subsequent studies
involving this sample suggested that common allelic
variations in the serotonin transporter gene (Wassink et
al. 2007) and the monoamine oxidase A gene (Davis et al.
2008) were associated with cortical enlargement in the
children with autism but not necessarily in control
subjects. Separate studies have implicated a role for the
HOXA1 A218G polymorphism on increased head circum-
ference in both children with autism (Conciatori et al.
2004) and normal controls(Muscarella et al. 2007).
Some studies have suggested that an increase in the rate
of head growth could be the result of an overall increase in
general body growth of autistic children (Fukumoto et al.
2008; Dawson et al. 2007; Torrey et al. 2004; van Daalen et
al. 2007). Dawson et al. (2007) and Fukumoto et al. (2008)
reported, however, that even after correcting for measure-
ments in the child’s body length and height, HC trajectories
were still accelerated in children with autism.
The current study builds on the existing scientific
literature on head growth in autism in three specific ways.
First, it examined sibling pairs, from 48 ASD-affected
families and 85 non-ASD families ascertained in the same
geographic region across completely overlapping birth
years. This allowed estimation of sibling correlation for
head growth in both ASD-affected and control sub samples,
which is directly relevant to the question of whether head
growth trajectory might constitute an autism endopheno-
type (see “Discussion”). In addition, the use of unaffected
contemporaneous sibling pairs averts the problem of basing
comparisons on norms generated in older or separately-
ascertained birth cohorts. Second, the study incorporated
quantitative trait measurements of autistic social impair-
ment among children with ASD and their siblings, which
allowed examination of the association between head
growth and the severity of autistic symptomatology, not
only in index ASD cases but in affected and unaffected
siblings. Finally, the sample was comprised of relatively
high-functioning ASD subjects, and therefore potentially
less-affected by the confound of cognitive impairment that
might separately relate to head growth abnormalities in
studies involving lower-functioning autistic subjects.
The head growth data for this study consisted of serial
orbitofrontal circumference measurements recorded by the
subjects’ pediatricians and acquired retrospectively from
their medical records. Although serial measurements of
orbitofrontal circumference are less precise than brain
volumes derived from neuroimaging procedures, the mea-
surement of HC represents (on a public health level) a risk
variable that can be feasibly and reliably obtained for
screening purposes in the general population. Previous
research has strongly supported the validity of HC
measurement as a proxy for brain volume in screening
(for example) for hydrocephalus and other forms of
macrocephaly. Hazlett et al. (2005) observed a coefficient
of correlation between HC measurements and total brain
volume of 0.88 in their sample of 18–35 month old infants
with and without autism. Similarly, in a sample of 230
preterm infants, Cheong et al. (2008) reported a strong
correlation (r=0.68) between HC and brain volume. The
reliability of HC measurements among the practitioners
who recorded the data acquired for this study is specifically
addressed in the “Methods” section of this report.
40 J Neurodevelop Disord (2010) 2:39–46Table 1 A summary of published studies comparing head growth in children with autism vs. controls
a
Study n ASD
a Dev.
period of
measurement
(months)
Mean IQ
of subjects
Control group Method of
measurement
1st year of
life principle
findings
12–36 month
significant
findings
Analytic
method
b
1. Courchesne
et al. 2003
48 Birth—14 75 CDC Norms/FELS
longitudinal
sample study
OFC
and MRI
Birth-14 month
(acceleration)
Cross-
sectional
2. Torrey
et al. 2004
15 Birth—14 56.8 NCPP (1959–1965
birth cohorts)
OFC Difference at
birth
but no
difference
in growth
trajectory
[no
difference]
Cross-
sectional,
growth
curve
3. Hazlett
et al. 2005
113 Birth—36 54.1 Contemporaneous
controls with
TYP
(n=178) or DD
(n=11)
OFC
and MRI
[no difference] 12–24
months
(acceleration)
Cross-
sectional,
growth
curve
analysis
4. Fukumoto
et al. 2008
85 Birth—12 75.5 JMHLW 2000
infant physical
growth survey
OFC 1–12 month
(acceleration)
Cross-
sectional
5. Elder
et al. 2008
(Study of 77
high- risk sibs)
Not
Reported
Birth—24 Not
Reported
2002 CDC Norms OFC Birth-12 month
(acceleration)
12–24
months
(deceleration)
Cross-
sectional,
multilevel
modeling
6. Dawson
et al. 2007
(deceleration)
28 Birth—36 61.5
(Mullen
Composite)
2002 CDC Norms OFC Birth-12 month
(acceleration)
12—36
months
(relative
deceleration)
Cross-
sectional,
growth
curve
7. Webb
et al. 2007
28 Birth—36 Not
Reported
2000 CDC Norms OFC 7–10 month
(acceleration)
Cross-
sectional
8. van Daalen
et al. 2007
53 Birth—64 <70: 33
70–85:6
1996, 1997
NOASR
OFC [no difference] [no difference] Cross-
sectional
>85: 14
9. Constantino
et al. [Current
Study]
48 Birth—36 92 Unaffected
sibs and
contemporaneous
control sib pairs
OFC Birth—15
month
(trend,
acceleration)
Cross-
sectional,
growth
curve
aNumber of ASD-affected subjects from unique families
bP-Values for principal differences between ASD subjects and controls
1. Comparison of 22 ASD infants vs. 31 controls with birth—14 month data indicated a significantly greater increase in HC, p<.001
2. At 4 months, the HC of the ASD subjects was not significantly larger than the HC of the controls (p=.07)
3. The growth curves for subjects with autism vs. controls were significantly different; p<.001 for all three parameters comprising the curves
4. In the low functioning ASD boys, HC differed from the controls at 1 month (p=.0008), 3 months (p=.025), and 6 months (p=.0001). The high
functioning ASD boys differed from the controls at 6 months (p=.02)
5. Whole group cross-sectional differences between high risk siblings and CDC norms are significantly different at 6–12 months, p<.05 at each
time point; birth—12 month slopes are greater than CDC norms, p<.001. Subset with significant ASD symptoms (Early Developmental Interview,
EDI or Modified Checklist for Autism in Toddlers, M-CHAT) vs. those without differed in 12–24 month HC slope (EDI, p=.05), and exhibited a
larger 12 month intercept (M-CHAT, p=.02)
6. The orbitofrontal circumference (OFC) z-score for the ASD subjects at 12 months was significantly larger than the control group’s( p<.001).
Although the rate of change of HC decreases from 12–36 months (p=.001), the rate of change does not significantly differ from that of the norms
(p=.409)
7. The mean OFC z-scores in the ASD group did not significantly differ from the controls from 0–7 months and from 10–13 months, but they
were significantly larger than the controls from 7–10 (p<.001) and 13–36 (p<.007) months
8. No significant difference between ASD subjects and controls were found
9. Growth curve trajectory for ASD subjects mildly accelerated in comparison controls for age range birth—15 months, p=.07. The magnitude of
difference was on the order of 0.03 cm/month
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Participants
Clinical sample: sibling pairs in ASD-affected families
Participants included a total of 48 sibling pairs, concordant
(N=20) and discordant (N=28) for ASD, who are subjects
in our ongoing 5-year longitudinal study of social devel-
opment at the Washington University (WU) School of
Medicine as previously described in Constantino et al.
(2006). The WU sample consists of families recruited from
the Child and Adolescent Psychiatry Service at WU and
local advertisements in the greater St. Louis metropolitan
area, who met the following inclusion criteria: one index
case affected by an ASD and a full biological male sibling
age 4–18 years. For the ASD group, the diagnosis of the
index child (in families with more than one affected child,
the most severely affected child in the family) was
confirmed by the Autism Diagnostic Interview-Revised
(ADIR), the Autism Diagnostic Observation Schedule
(ADOS), and expert clinician diagnosis. For all index
cases, the ADIR and ADOS were positive. Affected status
of siblings was confirmed by the same measures, which
were performed whenever there existed clinical suspicion
of an ASD diagnosis and/or a parent-report SRS score of 65
(raw) or greater. Nineteen of the index cases carried a
clinician diagnosis of autistic disorder and 29 were
individuals with clinical diagnoses of PDD-NOS or
Asperger syndrome. The average full-scale IQ of this
sample was 92 (SD 24). Forty-three of the probands were
male and all siblings were male. In cases where there were
multiple siblings of a clinically-ascertained proband, the
male sibling closest in age to the proband was selected for
inclusion in the study. Children born prematurely were
excluded from the study.
Non-clinical sample: sibling pairs from non-ASD (control)
families
Eighty-five unaffected male sibling pairs were used as a
source of contemporaneous controls. The controls were
recruited from the primary care service of Forest Park
Pediatrics which generally represents the ethnic and
socioeconomic distribution of families in the St. Louis
metropolitan area. Records for this service were reviewed
for the availability of prospectively acquired HC measure-
ments in the infants of families for whom at least two male
children (full siblings) were cared for and followed by the
practice from birth. Families were excluded from the study
if any one of the male siblings from the candidate pair
carried a primary or secondary diagnosis of autism,
prematurity, any neurological disorder, or serious chronic
disease beginning in infancy according to the electronic
medical record data from the practice. For these families,
de-identified HC growth charts were provided to our
research team in male sibling sets. This data acquisition
was reviewed and approved by the Washington University
Human Studies Committee and granted a waiver of consent
for the use of existing de-identified data.
The data from the growth curves was entered electron-
ically for all measurements depicted on the charts that were
made at ages birth, 1 month, 2 months, 4 months, 6 months,
9 months, 10 months, 12 months, 15 months, 18 months,
21 months, 24 months, 27 months, 30 months, and
36 months. Head circumference values were recorded from
entries on growth charts to the nearest 0.1 cm.
Measures
Head circumference
In our study, HC data was retrospectively ascertained from
growth charts available in the children’s pediatric records.
Pediatricians used standardized tape measures to obtain HC
data. All subjects had available measurements for at least
two time points (most often at 6 months and at least one
later date); most had multiple additional measurements
performed. All available measurements over the period
from birth to 36 months were incorporated into this study.
A listing of the total number of measurements is provided
in Table 2, listed as a function of subject group and age at
the time of measurement.
The validity of orbitofrontal circumference (OFC) as a
proxy or correlate of brain volume is described in the
“Introduction”. In this study OFC measurements were made
and recorded by a variety of pediatricians, eight physicians
participating in measurements of the control sample, and
numerous physicians contributing measurements for the
clinical sample. Therefore, an additional step in establishing
validity of these measurements involved examination of the
correlation between closely spaced measurements in individ-
ual subjects. For this we computed intra class coefficients of
correlation between 4 month and 6 month measurements and
between 12 month and 18 month measurements. The
intervening period from 6 months to 12 months represents
an inflection point in the normal trajectory of head growth,
the interval over which the plot of time verses HC levels off
from a vertical to a horizontal orientation. For 4–6m o n t h s
r=0.91, and for 12–18 months r=0.93, indicating a very
high degree of test-retest reliability for these measurements.
Social responsiveness scale (clinical sample only)
In addition to categorical designation of affected status,
index ASD cases and siblings in the clinical sample were
42 J Neurodevelop Disord (2010) 2:39–46assessed by their parents with respect to quantitative
severity ratings of autistic social impairment using a 65–
item rating scale, the Social Responsiveness Scale (SRS).
The validity and psychometric properties of the SRS have
been described extensively in previous published reports,
and are summarized in the SRS manual (Constantino and
Gruber 2005). Raw scores of 80 and above are highly
consistent with ASD in males. Mean SRS scores were 102
for autistic disorder probands with an SD of 25, 90 for
PDD-NOS/Asperger Disorder probands with an SD of 21,
107 for autistic disorder-affected siblings with an SD of 39,
85 for PDD-NOS/Asperger-affected siblings with an SD of
27, and 32 for non-ASD siblings with an SD of 29.
Data analysis
Time-rated change was estimated using two separate
methods. First, we conservatively derived monthly growth
rates from the time-rated change between measurements at
birth, 6 months, 12 months, and 18 months, because this
encompassed the developmental period over which a
substantial number of subjects had at least two contiguous
data points, and for which some previous studies have
indicated the most pronounced discrepancies between
autistic subjects and controls. Comparison of means for
each developmental interval, between children with autistic
disorder, children with PDD-NOS/Asperger Disorder, un-
affected siblings of ASD probands, and unaffected controls
was performed using Analysis of Variance (ANOVA).
Given that the only females in the study were five ASD
probands, we first restricted this analysis to males only, and
then repeated the analysis incorporating the female pro-
bands. In addition, Pearson’s coefficient of correlation
between head growth rates and autistic severity (measured
by the Social Responsiveness Scale) was computed for the
siblings in the ASD-affected families.
Next, in order to take advantage of all of the available
longitudinal measurements, linear and non-linear (qua-
dratic) components of change over time were estimated
from all available measurements on each subject, and
slope coefficients were derived (using the least squares
regression method) for each growth trajectory using SAS
statistical software. We used a method highly analogous
to that used for characterizing growth trajectory in
Hazlett et al. (2005) and Elder et al. (2008). In essence,
the growth curves were defined by an intercept, a
parameter for acceleration, and a parameter for decelera-
tion. Specifically, longitudinal measurement data was fit to
the equation y=b0+b1 (e^
(b2 * age)), where y = head
circumference; b0 = random effect; b1 = acceleration; and
b2 = deceleration. The coefficients were then compared
between ASD-affected subjects and unrelated controls
(selecting at random one sib per family) using logistic
regression methods, separately employing NLMIXED (in
which growth trajectories are incorporated at the level of
each individual subject) and NLIN in which all growth
trajectories for a group are averaged to a single trajectory
for group comparison. Finally, an omnibus test of
significance was computed as an indicator of overall
difference in growth trajectory across b0,b 1,a n db 2.
Results
Average rate of head growth over specific intervals
(within the range from birth to 18 months)—for which
male subjects had recorded measurement at the begin-
Month Index ASD subjects Sibs of ASD subject Control sib 1 Control sib 2
Birth 18 24 43 55
12 4 2 45 2 4 7
23 5 3 77 8 7 9
43 4 3 67 7 7 8
63 8 3 97 7 7 2
93 2 2 43 2 4 0
10 8 14 28 13
12 33 32 57 68
15 21 27 67 51
18 15 11 60 38
21 0 3 11 7
24 19 16 43 38
27 0 0 3 8
30 0 1 1 4
36 1 0 1 0
Table 2 Total number of head
circumference measurements in-
corporated in the study, as a
function of subject group and
age at the time of measurement
J Neurodevelop Disord (2010) 2:39–46 43ning and end—are presented for Autistic Disorder
subjects, PDD-NOS/Asperger’s subjects, unaffected sib-
lings of ASD probands, and control sibling pairs in
Table 3. As shown in the table, the differences between
the average rates of head growth between the four
groupings of subjects are subtle but generally in the
predicted direction except that the rates for unaffected sibs
of ASD probands were higher than for PDD/Asperger
probands for the 6–12 month and 12–18 month intervals.
With the exception of the interval from birth to 6 months
(F=2.78, dƒ3, 121, p=.04), the overall between-group
differences did not quite reach statistical significance (see
Table 3). The results were not significantly changed when
incorporating into the analysis the five female ASD
probands. As would be predicted from the mean rates of
change for affected and unaffected siblings of ASD
probands, there was no significant correlation between
head growth rate and autistic severity as measured by the
SRS in the sibling groups nor was there a significant
correlation among probands.
Sibling intra class correlation for the average rate of head
growth (from age 6–12 months, the developmental period
for which the greatest number of subjects had complete
data) in families affected by ASD was substantial, irre-
spective of whether the sibling of an index case was
affected or unaffected, and highly statistically significant:
ICC=.63. Similarly the correlation between male siblings in
the control families was positive and statistically significant
but the magnitude was not as great as that observed in the
autism families: ICC=.26. This difference was statistically
significant (p=.01) and raises the possibility that even in
the absence of clinically-appreciable mean differences in
head growth between ASD subjects and controls, genetic
factors associated with autism might operate to accentuate
sibling correlations for head growth trajectory.
Although group differences in the defining parame-
ters for the respective growth curves between ASD
subjects (N=48 probands) and unrelated controls (N=85,
1 per family selected at random) were in the expected
direction—as illustrated in the depiction of averaged
growth trajectories generated by NLIN in Fig. 1—they
failed to reach statistical significance in either of the
regression paradigms employed (NLIN, NLMIXED). In
essence, head size in children with ASD began slightly
lower than that of control subjects (Z=−1.790; p=.07),
proceeded at a mildly accelerated growth rate through the
age of 15 months (Z=1.795; p=.07) at which time the
curves crossed and head growth in ASD subjects deceler-
ated to a lesser extent than in the control group (Z=−1.32;
p=.18), as depicted in Fig. 1. An omnibus test of
significance of overall difference in growth trajectories
just reached statistical significance (p=.04).
Discussion
In this quasi-longitudinal study involving retrospectively-
acquired serial measurements of infant head growth in
children with autism spectrum disorders (ASD), their male
siblings, and unaffected male sibling pairs, head growth
trajectories did not predict which male siblings of index
autism cases went on to develop ASD, nor did they predict
severity among those affected with clinical-level or sub-
clinical symptomatology. We observed a slight relative
acceleration in head growth trajectory in ASD subjects
compared to controls, but the difference would not be
feasibly measurable using standard clinical methods (i.e.
tape measurement of orbitofrontal circumference), since it
was on the order of millimeters. A striking finding of the
study was the degree of familiality of head growth
trajectories, parameterized in this study by sib correlation,
which was significant for both autism families (irrespective
of whether the siblings were concordant or discordant for
ASD) and control families. The sib correlations were
Table 3 Comparison of mean head growth, in cm./month (SD) for specified intervals, between male subjects with Autistic Disorder, PDD-NOS/
Asperger Disorder, unaffected siblings of ASD probands, and unrelated controls. Analysis (one-way ANOVA) includes only those subjects with
actual measurements at the beginning and end of each interval (i.e. not extrapolated from growth curves defined by measurements at other time
points)
Birth-6months 6–12months 12–18months
Autistic disorder 1.68 (.17) .51 (.13) .28 (.13)
PDD-NOS/Asperger disorder 1.63 (.28) .53 (.13) .20 (.09)
Unaffected sibs of ASD probands 1.55 (.27) .56 (.13) .31 (.06)
Control siblings 1.51 (.18) .49 (.11) .24 (.08)
F 2.78 2.44 2.55
df 3,121 3,172 3,86
p .04 .07 .06
2000 CDC norms 1.26 0.41 0.23
Table 3 Comparison of mean head growth, in cm./month (SD) for
specified intervals, between male subjects with Autistic Disorder, PDD-
NOS/Asperger Disorder, unaffected siblings of ASD probands, and
unrelated controls. Analysis (one-way ANOVA) includes only those
subjects with actual measurements at the beginning and end of each
interval (i.e. not extrapolated from growth curves defined by measure-
ments at other time points)
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gesting that it is possible that within this group, there are
inherited factors which might incur greater uniformity of
head growth trajectory among siblings. If these inherited
factors are related to those that cause autism, head growth
trajectory may constitute a candidate autism endopheno-
type, i.e. an inherited substrate for autism susceptibility
which, alone, is not sufficient to produce an autistic
syndrome. We suggest this cautiously, since our results
showed a marginal difference in head growth trajectory
between children with autism and contemporaneous con-
trols. It is noteworthy that in this study the contemporane-
ous controls themselves, ascertained from a general
pediatric clinic, exhibited rates of early head growth that
exceeded CDC norms published in 2000. In future research
it would be important to track whether similar studies in
typical populations provide evidence for sustained trends in
rate of head growth in children.
We note that other recent studies have identified familial
aggregationofneuropsychologicalcorrelatesofautismthatdo
not necessarily predict clinical-level autistic impairment of
relatives (Dawson et al. 2007;D a l t o ne ta l .2007; Virkud et
al. 2008). The elucidation of endophenotypes is potentially
important since endophenotypes constitute phenotypic
markers with which to trace specific components of
susceptibility to the development of an inherited condition.
Thus, although accelerated head growth might reflect a
parameter of risk for autism, these data suggest that such a
factor would need to interact with another factor (or factors)
to contribute susceptibility to the autistic phenotype.
The design of this study obviated some of the limitations
that have potentially influenced contrasting results in
previously-reported research on this topic. The use of a
contemporaneous control sample helped to minimize differ-
ences that might have been suggested if the growth
trajectories of our ASD subjects were compared to
historical (previously published) norms, however this
particular set of control subjects may not necessarily
represent the general population. We employed both
cross-sectional comparisons and growth curve modeling in
the analysis of data, and the results from both approaches
were highly convergent. Given the known heritability of
autistic syndromes, we were particularly interested in
examining head growth and its relationship to autistic
impairment within a sibling design, and this study was the
first to implement such a design for both the ASD and
control groups. In addition, and with the exception of five
female index ASD cases, the sample was comprised
entirely of males. Sibling recurrence in autism is three to
four times higher in males than in females, so the exclusive
enrollment of male siblings enhanced power to explore
relationships between head growth trajectory and affected
status in siblings.
Finally, and possibly an important cause of differences
between these results and those of other published studies,
it is important to note that our sample of ASD-affected
children was relatively high-functioning (as operationalized
by higher measured average IQ); this served to minimize
possible effects of co-morbid mental retardation on head
growth trajectories within this ASD sample. We note that
Courchesne et al. (2003) observed that acceleration in head
growth trajectory appreciable among their autistic subjects
was less pronounced in patients with PDD-NOS. This
discrepancy as a function of “severity of diagnosis” is
possibly congruent with our findings of minimal abnormal-
ity in a generally higher-IQ ASD sample (encompassing
both autistic disorder and Asperger Disorder/PDD-NOS). It
is possible that cognitive impairment, specific causal
mechanisms (e.g. among the many genetic pathways to
autistic syndromes), or other parameters predicting func-
tional severity may exert independent effects on head
growth trajectory. Chiu et al (2007) for example, compared
22 boys with Fragile X Syndrome and Autistic Disorder to
22 boys with Fragile X Syndrome alone and observed
different trajectories of growth from 12–60 months for the
two groups: neither group differed from norms during the
first year of life, and Fragile X only subjects exhibited
greater head circumference than Fragile X plus autism
subjects at 60 months. Williams et al. (2008) have recently
reviewed and described the wide diversity of genetic
conditions that result in macrocephaly in childhood. It is
not yet known how infant head growth trajectories map to
variations in head circumference later in life; however, we
note that a large scale study of head size, measured cross-
sectionally at a single time point in 3- to 47-year-old
individuals with autism and their first-degree relatives
(Lainhart et al. 2006) demonstrated: a) no significant mean
difference between affected and unaffected siblings of ASD
probands; and b) substantial correlations in head size
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Fig. 1 Average head circumference, computed in Proc NLIN as a
function of age in subjects with ASD (lighter curve) versus controls
(darker curve)
J Neurodevelop Disord (2010) 2:39–46 45between affected individuals and their unaffected parents,
yielding heritability estimates on the order of 0.50.
Limitations of this study included sample size, the
exclusive use of retrospectively-acquired head circumference
measurements (rather than neuroimaging data), and missing
data points in the medical records from which the measure-
ments were retrieved. The latter was abrogated by the growth
curve modeling methods used, but the primary limitation—
sample size—remains an important consideration, especially
given the relatively narrow margin of difference observed
between ASD and control subjects in our sample. There are
currently efforts under way to pool prospective data on the
head growth of infant siblings of children with autism across
multiple study sites (for example, the NICHD BabySibs
Consortium). We eagerly await the results of these efforts and
hope that the sibling data from our control sample will be
particularly useful for the interpretation of those results. In the
mean time, the data from the relatively modest number of
ASD-affected children in this study suggest that the magni-
tude of difference in the growth trajectory of affected versus
unaffected infants may be very difficult to ascertain manually
in clinical settings. At this point, unless head growth
trajectories of infants are grossly abnormal (i.e. reaching
clinical parameters for microcephaly or macrocephaly) they
should be interpreted cautiously in predicting affectation
status among later-born siblings of children with autism.
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